Somatosensory amplification moderates the efficacy of internet-delivered CBT for somatic symptom distress in emerging adults: Exploratory analysis of a randomized controlled trial
- Publikationstyp:
- Zeitschriftenaufsatz
- Metadaten:
-
- Autoren
- Severin Hennemann
- Michael Witthoeft
- Maria Kleinstaeuber
- Katja Boehme
- Harald Baumeister
- David Daniel Ebert
- Thomas Probst
- Autoren-URL
- https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=fis-test-1&SrcAuth=WosAPI&KeyUT=WOS:000793129100003&DestLinkType=FullRecord&DestApp=WOS_CPL
- DOI
- 10.1016/j.jpsychores.2022.110761
- eISSN
- 1879-1360
- Externe Identifier
- Clarivate Analytics Document Solution ID: 1C4ZL
- PubMed Identifier: 35182889
- ISSN
- 0022-3999
- Zeitschrift
- JOURNAL OF PSYCHOSOMATIC RESEARCH
- Schlüsselwörter
- Internet-delivered cognitive behavioral therapy
- Randomized controlled trial
- Moderators
- Somatic symptom distress
- Somatosensory amplification
- Artikelnummer
- ARTN 110761
- Datum der Veröffentlichung
- 2022
- Status
- Published
- Titel
- Somatosensory amplification moderates the efficacy of internet-delivered CBT for somatic symptom distress in emerging adults: Exploratory analysis of a randomized controlled trial
- Sub types
- Article
- Ausgabe der Zeitschrift
- 155
Datenquelle: Web of Science (Lite)
- Andere Metadatenquellen:
-
- Autoren
- Severin Hennemann
- Michael Witthöft
- Maria Kleinstäuber
- Katja Böhme
- Harald Baumeister
- David Daniel Ebert
- Thomas Probst
- DOI
- 10.1016/j.jpsychores.2022.110761
- ISSN
- 0022-3999
- Zeitschrift
- Journal of Psychosomatic Research
- Sprache
- en
- Artikelnummer
- 110761
- Paginierung
- 110761 - 110761
- Datum der Veröffentlichung
- 2022
- Status
- Published
- Herausgeber
- Elsevier BV
- Herausgeber URL
- http://dx.doi.org/10.1016/j.jpsychores.2022.110761
- Datum der Datenerfassung
- 2022
- Titel
- Somatosensory amplification moderates the efficacy of internet-delivered CBT for somatic symptom distress in emerging adults: Exploratory analysis of a randomized controlled trial
- Ausgabe der Zeitschrift
- 155
Datenquelle: Crossref
- Abstract
- <h4>Objective</h4>While studies mainly provide positive evidence for the efficacy of internet-delivered cognitive-behavioral therapy (ICBT) for various persistent somatic symptoms, it remains largely unclear for whom these interventions work or not. This exploratory analysis aimed to identify moderators for the outcome between ICBT for somatic symptom distres and a waitlist control group (WL) in a vulnerable target group of emerging adults.<h4>Methods</h4>Based on data from a randomized controlled trial on 156 university students with varying degrees of somatic symptom distress who were allocated to either an eight-week, therapist guided ICBT (iSOMA) or to the WL, we examined pretreatment demographic characteristics, health-related variables (e.g., somatic symptom duration), mental distress (e.g., depression, anxiety) and cognitive-emotional factors (emotional reactivity, somatosensory amplification) as candidate moderators of the outcome, somatic symptom distress (assessed by the Patient Health Questionnaire, PHQ-15) from pre- to posttreatment.<h4>Results</h4>Somatosensory amplification (assessed by the Somatosensory Amplification Scale, SSAS) moderated the outcome in favor of iSOMA (B = -0.17, SE = 0.08, p = 0.031), i.e., higher pretreatment somatosensory amplification was associated with better outcome in the active compared to the control intervention. No significant moderation effects were found among demographic characteristics, health-related variables, or mental distress.<h4>Conclusion</h4>Our findings suggest that an internet-delivered CBT for somatic symptom distress should be preferred over no active treatment particularly in individuals with moderate to high levels of somatosensory amplification, which as a next step should be tested against further treatments and in clinical populations.<h4>Trial registration</h4>German Clinical Trials Register (DRKS00014375).
- Addresses
- Johannes Gutenberg University Mainz, Department of Clinical Psychology, Psychotherapy and Experimental Psychopathology, Mainz, Germany. Electronic address: s.hennemann@uni-mainz.de.
- Autoren
- Severin Hennemann
- Michael Witthöft
- Maria Kleinstäuber
- Katja Böhme
- Harald Baumeister
- David Daniel Ebert
- Thomas Probst
- DOI
- 10.1016/j.jpsychores.2022.110761
- eISSN
- 1879-1360
- Externe Identifier
- PubMed Identifier: 35182889
- Open access
- false
- ISSN
- 0022-3999
- Zeitschrift
- Journal of psychosomatic research
- Schlüsselwörter
- Humans
- Treatment Outcome
- Anxiety Disorders
- Internet
- Adult
- Medically Unexplained Symptoms
- Cognitive Behavioral Therapy
- Sprache
- eng
- Medium
- Print-Electronic
- Online publication date
- 2022
- Paginierung
- 110761
- Datum der Veröffentlichung
- 2022
- Status
- Published
- Datum der Datenerfassung
- 2022
- Titel
- Somatosensory amplification moderates the efficacy of internet-delivered CBT for somatic symptom distress in emerging adults: Exploratory analysis of a randomized controlled trial.
- Sub types
- Research Support, Non-U.S. Gov't
- Randomized Controlled Trial
- Journal Article
- Ausgabe der Zeitschrift
- 155
Datenquelle: Europe PubMed Central
- Abstract
- OBJECTIVE: While studies mainly provide positive evidence for the efficacy of internet-delivered cognitive-behavioral therapy (ICBT) for various persistent somatic symptoms, it remains largely unclear for whom these interventions work or not. This exploratory analysis aimed to identify moderators for the outcome between ICBT for somatic symptom distres and a waitlist control group (WL) in a vulnerable target group of emerging adults. METHODS: Based on data from a randomized controlled trial on 156 university students with varying degrees of somatic symptom distress who were allocated to either an eight-week, therapist guided ICBT (iSOMA) or to the WL, we examined pretreatment demographic characteristics, health-related variables (e.g., somatic symptom duration), mental distress (e.g., depression, anxiety) and cognitive-emotional factors (emotional reactivity, somatosensory amplification) as candidate moderators of the outcome, somatic symptom distress (assessed by the Patient Health Questionnaire, PHQ-15) from pre- to posttreatment. RESULTS: Somatosensory amplification (assessed by the Somatosensory Amplification Scale, SSAS) moderated the outcome in favor of iSOMA (B = -0.17, SE = 0.08, p = 0.031), i.e., higher pretreatment somatosensory amplification was associated with better outcome in the active compared to the control intervention. No significant moderation effects were found among demographic characteristics, health-related variables, or mental distress. CONCLUSION: Our findings suggest that an internet-delivered CBT for somatic symptom distress should be preferred over no active treatment particularly in individuals with moderate to high levels of somatosensory amplification, which as a next step should be tested against further treatments and in clinical populations. TRIAL REGISTRATION: German Clinical Trials Register (DRKS00014375).
- Date of acceptance
- 2022
- Autoren
- Severin Hennemann
- Michael Witthöft
- Maria Kleinstäuber
- Katja Böhme
- Harald Baumeister
- David Daniel Ebert
- Thomas Probst
- Autoren-URL
- https://www.ncbi.nlm.nih.gov/pubmed/35182889
- DOI
- 10.1016/j.jpsychores.2022.110761
- eISSN
- 1879-1360
- Zeitschrift
- J Psychosom Res
- Schlüsselwörter
- Internet-delivered cognitive behavioral therapy
- Moderators
- Randomized controlled trial
- Somatic symptom distress
- Somatosensory amplification
- Adult
- Anxiety Disorders
- Cognitive Behavioral Therapy
- Humans
- Internet
- Medically Unexplained Symptoms
- Treatment Outcome
- Sprache
- eng
- Country
- England
- Paginierung
- 110761
- PII
- S0022-3999(22)00046-0
- Datum der Veröffentlichung
- 2022
- Status
- Published
- Datum, an dem der Datensatz öffentlich gemacht wurde
- 2022
- Titel
- Somatosensory amplification moderates the efficacy of internet-delivered CBT for somatic symptom distress in emerging adults: Exploratory analysis of a randomized controlled trial.
- Sub types
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- Ausgabe der Zeitschrift
- 155
Datenquelle: PubMed
- Beziehungen:
- Eigentum von